Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension

Eur J Pharmacol. 2021 Jun 5:900:174046. doi: 10.1016/j.ejphar.2021.174046. Epub 2021 Mar 19.

Abstract

This study is designed to investigate the role of novel protein kinases C (nPKC) in mediating pulmonary artery smooth muscle cells (PASMCs) proliferation in pulmonary hypertension (PH) and the underlying mechanisms. Mouse PASMCs was isolated using magnetic separation technology. The PASMCs were divided into 24 h group, 48 h group and 72 h group according to different hypoxia treatment time, then detected cell proliferation rate and nPKC expression level in each group. We treated PASMCs with agonists or inhibitors of PKCdelta (PKCδ) and PKCepsilon (PKCε) and exposed them to hypoxia or normoxia for 72 h, then measured the proliferation of PASMCs. We also constructed a lentiviral vector containing siRNA fragments for inhibiting PKCδ and PKCε to transfected PASMCs, then examined their proliferation. PASMCs isolated successfully by magnetic separation method and were in good condition. Hypoxia promoted the proliferation of PASMCs, and the treatment for 72 h had the most significant effect. Hypoxia upregulated the expression of PKCδ and PKCε in mouse PASMCs, leading to PASMCs proliferation. Moreover, Our study demonstrated that hypoxia induced upregulation of PKCδ and PKCε expression resulting to the proliferation of PASMCs via up-regulating the phosphorylation of AKT and ERK. Our study provides clear evidence that increased nPKC expression contributes to PASMCs proliferation and uncovers the correlation between AKT and ERK pathways and nPKC-mediated proliferation of PASMCs. These findings may provide novel targets for molecular therapy of pulmonary hypertension.

Keywords: Hypoxia; Novel protein kinase C; Proliferation; Protein kinase C; Pulmonary artery smooth muscle cells; Pulmonary hypertension.

MeSH terms

  • Animals
  • Cell Hypoxia / physiology*
  • Cell Proliferation
  • Hypertension, Pulmonary / pathology*
  • MAP Kinase Signaling System / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Smooth Muscle*
  • Oncogene Protein v-akt / drug effects
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / biosynthesis*
  • Protein Kinase C-delta / drug effects
  • Protein Kinase C-epsilon / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • Pulmonary Artery / pathology*
  • Up-Regulation / physiology

Substances

  • Protein Kinase Inhibitors
  • Oncogene Protein v-akt
  • Protein Kinase C
  • Protein Kinase C-delta
  • Protein Kinase C-epsilon